MedTrace Logo

Limited Access Protocol for the Use of Oral Cisapride

NCT02524496 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2015-08-14

No results posted yet for this study

Summary

Due to the lack of other drugs to treat gastroparesis Janssen and FDA approved the compassionate use of cisapride to treat patients who had no other effective therapy. For this observational study, 3 patients who had already been prescribed cisapride by outside physicians, were followed to determine the effectiveness of cisapride on their gastric emtpying.

Conditions

Sponsors & Collaborators

  • Yale University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-03-31
Primary Completion
2011-03-31
Completion
2011-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02524496 on ClinicalTrials.gov